Recent Finacing
Recent Raise
Methylation Sciences (MSI) is a Vancouver-based clinical-stage pharma developing Strada (MSI-195), an oral SAMe-derived small-molecule adjunctive therapy for Major Depressive Disorder, tested in Phase 2 trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors